Of note, the observed enrichment in ABC transporters and pathways associated to lipid metabolism in mice treated with the vehicle is consistent with human findings showing significant over-representation of these pathways in patients with atherosclerotic cardiovascular disease, cirrhosis, obesity, and type-2 diabetes [32]. This evidence concerns the gene ABCG2 and type 2 diabetes mellitus.